Browse News
Filter News
Found 1,186 articles
-
Biologics Market Size to Hit Around USD 1. 37 Trillion By 2033
4/17/2024
According to the latest Research by Nova One Advisor, the global biologics market size was exhibited at USD 511.04 billion in 2024 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period 2024 to 2033.
-
Prescriptions for Sandoz’s Hyrimoz, a biosimilar version of AbbVie’s Humira, have shot up after CVS Caremark took the blockbuster arthritis treatment off its major national commercial formularies on April 1.
-
U.S. Biopharmaceutical CMO & CRO Market Size, Share & Growth Report, 2033
4/15/2024
The U.S. biopharmaceutical CMO & CRO market size was estimated at USD 10.82 billion in 2023 and is projected to hit around USD 19.75 billion by 2033, growing at a CAGR of 6.2% during the forecast period from 2024 to 2033.
-
Biologics Contract Development Market Size to Hit USD 18.68 Bn by 2033 | CAGR 8.2%
4/15/2024
According to Nova One Advisor, the global biologics contract development market size was accounted for USD 8.49 billion in 2023 and it is increasing around USD 18.68 billion by 2033 with a CAGR of 8.2% from 2024 to 2033.
-
Even with discounts that reach as high as 86%, Humira biosimilars are finding it difficult to take market share away from the AbbVie blockbuster, according to a new report from Samsung Bioepis.
-
Samsung Bioepis Releases Second Quarter 2024 US Biosimilar Market Report
4/8/2024
Samsung Bioepis Co., Ltd. released its Second Quarter 2024 Biosimilar Market Report, which includes the latest Average Sales Price information of all biosimilars and reference products available in the US market.
-
Due to slow uptake of its Humira biosimilar Cyltezo in the U.S., Boehringer Ingelheim is laying off an undisclosed number of its sales employees, Reuters reported on Thursday.
-
Cell And Gene Therapy Manufacturing Market is Rising Rapidly
4/4/2024
The global cell and gene therapy manufacturing market size was evaluated at USD 9.95 billion in 2023 and is expected to attain around USD 106.03 billion by 2033
-
NeoImmuneTech Appoints Dr. Luke Oh, Ph.D. as New Chief Executive Officer
4/2/2024
NeoImmuneTech, Inc., announced that Luke Oh, Ph.D. has been appointed as President and Chief Executive Officer of NeoImmuneTech, Inc., effective from March 29, 2024.
-
Microbiology Testing Market Experiencing Rapid Growth
4/1/2024
The global microbiology testing market size was valued at USD 5.33 billion in 2023 and it is expected to surpass around USD 12.72 billion by 2033 with a CAGR of 9.12% from 2024 to 2033 due to the increasing demand for genetic testing services.
-
Cell And Gene Therapy CDMO Market Size to Reach USD 69.11 Bn by 2033
3/28/2024
The global cell and gene therapy CDMO Market size was valued at USD 5.90 billion in 2023 and is projected to reach USD 69.11 billion by 2033,
-
Biopharmaceuticals Contract Manufacturing Market Size To Hit USD 31.92 Bn By 2032
3/27/2024
According to the latest research by nova one advisor, the global biopharmaceuticals contract manufacturing market size was exhibited at USD 19.89 billion in 2023 and is projected to hit around USD 31.92 billion by 2032, growing at a CAGR of 5.4% during the forecast period 2023 to 2032.
-
Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201: A Promising Approach to Address Under Medical Needs
3/26/2024
Aptamer Sciences Inc. announced the filing of an Investigational New Drug application for the phase 1 clinical trial of AST-201 with the Korean Ministry of Food and Drug Safety on March 12th, 2024.
-
Samsung Accepts Healthcare Innovator Award for Contribution to Care in Underserved Communities
3/20/2024
Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, was awarded HHM Health’s Healthcare Innovator Award for its SonoSync technology and contributions to closing the gap in quality, accessible healthcare for underserved communities.
-
PocketHealth Raises $33M USD in Series B Funding to Transform Medical Image Exchange and Patient Experience
3/20/2024
PocketHealth, the leader in patient-centric medical image exchange, announced it has raised $33 million USD in Series B funding.
-
Samsung Invests in BrickBio to Develop Advanced Molecules and Therapies Using Protein Engineering Technology for Antibody-Drug Conjugates (ADC)
3/18/2024
Samsung Life Science Fund, created jointly between Samsung Biologics, Samsung Bioepis, and Samsung C&T, and managed by Samsung Ventures, and BrickBio, Inc. announced Samsung's investment in BrickBio, a preclinical-stage biopharmaceutical company focused on developing precision biologics using an expanded genetic code.
-
Sandoz reports fourth quarter 2023 sales and full-year 2023 results
3/13/2024
Sandoz, the global leader in generic and biosimilar medicines, announced net sales for the fourth quarter and results for the full year ended December 31, 2023.
-
Samsung Bioepis Presents Two Abstracts for Its Immunology Portfolio at the 2024 American Academy of Dermatology (AAD) Annual Meeting
3/9/2024
Samsung Bioepis Co., Ltd. presented two new study results for its immunology portfolio – SB5, a biosimilar to Humira, and SB17, a proposed biosimilar to Stelara2 – at the 2024 American Academy of Dermatology Annual Meeting being held from March 8 to 12 in San Diego, California, United States.
-
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
3/1/2024
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”) today announced its financial results for the fourth quarter and full year ended December 31, 2023.
-
On Friday, Alvotech and Teva Pharmaceuticals finally secured the FDA’s greenlight for their Humira biosimilar Simlandi, which now has the regulator’s interchangeability designation.